Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesImpact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective
Current Medical Research and Opinion, 08/11/09
Boonen S et al. – Although treatment persistence is an important factor in reducing fracture risk, when comparing the health economic data of several treatment options, studies have shown that the cost–effectiveness of bisphosphonate therapy is mainly dependent on drug efficacy rather than persistence or dosing frequency. It should also be noted that fractures at different skeletal sites have different economic impacts. Non–vertebral fractures (and particularly those of the hip) are more costly than vertebral fractures. Although persistence with osteoporosis therapy is an important factor in reducing fracture risk, it has less of an impact on cost–effectiveness than treatment efficacy, in particular efficacy at non–vertebral sites.
Related Articles
Osteogenesis imperfecta: questions and answers
Current Opinion in Pediatrics, 11/13/09
Relevance Score: 67%
Bisphosphonates in breast cancer: teaching an old dog new tricks
Current Opinion in Oncology, 10/12/09
Relevance Score: 67%
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA
Osteoporosis International, 10/06/09
Relevance Score: 67%
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Relevance Score: 66%
Long-Term Effects of Pamidronate in Thalassemic Patients with Severe Bone Mineral Density Deficits
Hemoglobin, 10/23/09
Relevance Score: 66%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases
Current Medical Research and Opinion, 12/18/09
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/18/09
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
European Journal of Pain, 12/18/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
Current Medical Research and Opinion, 12/18/09
Costs of hospital-based methadone maintenance treatment in HIV/AIDS control among injecting drug users in Indonesia
Health Policy, 12/16/09
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor